Tingyan He
Overview
Explore the profile of Tingyan He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gottlieb S, Shang W, Ye D, Kubo S, Jiang P, Shafer S, et al.
Proc Natl Acad Sci U S A
. 2024 Oct;
121(44):e2416722121.
PMID: 39436665
T cell receptor (TCR) engagement causes a global cellular response that entrains signaling pathways, cell cycle regulation, and cell death. The molecular regulation of mRNA translation in these processes is...
2.
Zhu X, Fan J, Huang Y, Xu Y, Yang Z, Weng R, et al.
Pediatr Rheumatol Online J
. 2024 Sep;
22(1):87.
PMID: 39334417
Objective: Cryopyrin-associated periodic syndrome (CAPS) is characterized by excessive IL-1β release resulting in systemic and organ inflammation. As an anti-IL-1 agent, canakinumab has been approved with all CAPS phenotypes in...
3.
Yang Z, Tao P, Han X, Kozlova A, He T, Volchkov E, et al.
Arthritis Rheumatol
. 2024 Jul;
76(11):1670-1678.
PMID: 38965708
Objective: Autoinflammation and phospholipase C (PLC) γ2-associated antibody deficiency and immune dysregulation (APLAID) syndrome is an autoinflammatory disease caused by gain-of-function variants in PLCG2. This study investigates the pathogenic mechanism...
4.
He T, Wang L, Huang X, Weng R, Yang J
Clin Immunol
. 2024 Jun;
265:110290.
PMID: 38944365
Objective: Juvenile arthritis caused by loss-of-function LACC1 mutations is characterized by early onset of symmetric and chronic arthritis, associated with an elevation of inflammatory markers. We aimed to describe serum...
5.
Zhu X, Weng R, Huang Y, Xu Y, Yang J, He T
Front Pediatr
. 2024 Mar;
12:1349907.
PMID: 38550627
Objective: Systemic juvenile idiopathic arthritis (sJIA) is characterized by excessive production of proinflammatory cytokines. As an anti-IL-1 agent, canakinumab has been approved in the USA and Europe for the treatment...
6.
He T, Shen Z, Ling J, Zhu X, Yang J
Pediatr Rheumatol Online J
. 2023 Aug;
21(1):88.
PMID: 37608293
Background: Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. The diagnosis of KFD can be challenging for nonspecific symptoms, laboratory or imaging findings. In this study, we aimed...
7.
Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
He T, Ling J, Yang J
Sci Rep
. 2023 Jun;
13(1):9050.
PMID: 37270663
Systemic juvenile idiopathic arthritis (SJIA) is a chronic inflammatory disease of childhood with elevated serum IL-6 levels. As an inhibitor of IL-6R, tocilizumab (TCZ) has been approved to treat SJIA...
8.
He T, Xia Y, Luo Y, Yang J
Front Pediatr
. 2023 May;
11:1134312.
PMID: 37152309
Objective: Systemic juvenile idiopathic arthritis (SJIA) is characterized by excessive and inappropriate production of proinflammatory cytokines. Janus kinase inhibitors (JAKi) can block the downstream pathway of many cytokines. The use...
9.
Shen Z, Ling J, Zhu X, Yang J, He T
Pediatr Rheumatol Online J
. 2023 Jan;
21(1):10.
PMID: 36698152
Background: Kikuchi-Fujimoto disease (KFD) is typically a benign, self-limiting inflammatory disease. However, some patients may have a prolonged or recurrent disease course, or present with life-threatening complications such as macrophage...
10.
Wang L, Luo Y, Li X, Li Y, Xia Y, He T, et al.
Mycopathologia
. 2022 Sep;
187(5-6):455-467.
PMID: 36180657
Purpose: Talaromyces marneffei (TM) is an opportunistic fungus leading to multi-organ damages and poor prognosis in immunocompromised individuals. TM infections in children are rare and our knowledge to TM infection...